Cigna Group $CI Shares Bought by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. lifted its position in shares of Cigna Group (NYSE:CI) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 118,250 shares of the health services provider’s stock after buying an additional 2,200 shares during the period. Crossmark Global Holdings Inc.’s holdings in Cigna Group were worth $32,546,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in CI. Beacon Financial Strategies CORP acquired a new stake in Cigna Group during the fourth quarter worth about $28,000. Lodestone Wealth Management LLC acquired a new position in shares of Cigna Group in the 4th quarter valued at about $32,000. Collier Financial acquired a new position in shares of Cigna Group in the 3rd quarter valued at about $34,000. Activest Wealth Management grew its holdings in shares of Cigna Group by 1,050.0% during the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock worth $38,000 after purchasing an additional 126 shares during the period. Finally, True Wealth Design LLC increased its position in Cigna Group by 116.4% during the 4th quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock worth $43,000 after purchasing an additional 85 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

CI opened at $288.01 on Friday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The firm has a market cap of $76.19 billion, a price-to-earnings ratio of 12.21, a PEG ratio of 0.99 and a beta of 0.30. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a fifty day simple moving average of $274.29 and a 200 day simple moving average of $276.32.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts expect that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is 26.45%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. The Goldman Sachs Group lifted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Robert W. Baird set a $337.00 price objective on shares of Cigna Group in a research report on Friday, May 1st. Wells Fargo & Company raised their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Barclays upped their price target on shares of Cigna Group from $303.00 to $310.00 and gave the stock an “overweight” rating in a research report on Friday, May 1st. Finally, Royal Bank Of Canada increased their price target on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.35.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.